BBVA USA Bancshares’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

BBVA USA Bancshares’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,356	Closed	-$473K	–	666
2019 Q4	$473K	Buy	+10,356	New	+$411K	0.03%	387
2018 Q3	–	Sell	-5,920	Closed	-$255K	–	550
2018 Q2	$255K	Hold	5,920	–	–	0.02%	480
2018 Q1	$248K	Hold	5,920	–	–	0.02%	483
2017 Q4	$258K	Hold	5,920	–	–	0.02%	478
2017 Q3	$252K	Hold	5,920	–	–	0.02%	477
2017 Q2	$255K	Hold	5,920	–	–	0.02%	485
2017 Q1	$248K	Hold	5,920	–	–	0.02%	502
2016 Q4	$231K	Hold	5,920	–	–	0.02%	506
2016 Q3	$262K	Hold	5,920	–	–	0.02%	485
2016 Q2	$247K	Hold	5,920	–	–	0.02%	475
2016 Q1	$238K	Hold	5,920	–	–	0.02%	471
2015 Q4	$303K	Buy	+5,920	New	+$302K	0.02%	410

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

FMP

Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

BBVA USA Bancshares's XPH Position: Q1 2020 in Review

BBVA USA Bancshares sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2020, closing a stake of 10,356 shares — an estimated $473K sold.

BBVA USA Bancshares first reported a position in XPH in Q4 2015 and held it in 12 quarters. The position peaked at $473K in Q4 2019. 66 funds tracked by Wall St. Rank hold XPH as of Q1 2020.

BBVA USA Bancshares reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2020 after selling out during the quarter.
BBVA USA Bancshares sold 10,356 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2020, an estimated $473K.
BBVA USA Bancshares first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2015 and held it in 12 quarters.
BBVA USA Bancshares's State Street SPDR S&P Pharmaceuticals ETF position peaked at $473K in Q4 2019.
66 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2020.

Based on BBVA USA Bancshares's 13F filing for Q1 2020, filed 27 Apr 2020.